Considering the attention that GDF-15 has received as a potential prognostic biomarker in neoplastic disease, we examined the serum concentrations of GDF-15 in an ambulatory population within the continuum of MM, ranging from asymptomatic up to overt MM (staged according to ISS). This evidence concerns the gene GDF15 and neoplasm.